Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis

Bibliographic Details
Main Authors: V. Urbonas, A. Zalimas, D. Dabkeviciene, A. Ulys, A. Matulevicius, F. Jankevicius, S. Jarmalaite
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320362339
_version_ 1818379941310365696
author V. Urbonas
A. Zalimas
D. Dabkeviciene
A. Ulys
A. Matulevicius
F. Jankevicius
S. Jarmalaite
author_facet V. Urbonas
A. Zalimas
D. Dabkeviciene
A. Ulys
A. Matulevicius
F. Jankevicius
S. Jarmalaite
author_sort V. Urbonas
collection DOAJ
first_indexed 2024-12-14T02:10:47Z
format Article
id doaj.art-f00b2b01b8da4cab84dda8945eb8abca
institution Directory Open Access Journal
issn 2666-1683
language English
last_indexed 2024-12-14T02:10:47Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series European Urology Open Science
spelling doaj.art-f00b2b01b8da4cab84dda8945eb8abca2022-12-21T23:20:46ZengElsevierEuropean Urology Open Science2666-16832020-11-0121S186Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysisV. UrbonasA. ZalimasD. DabkevicieneA. UlysA. MatuleviciusF. JankeviciusS. Jarmalaitehttp://www.sciencedirect.com/science/article/pii/S2666168320362339
spellingShingle V. Urbonas
A. Zalimas
D. Dabkeviciene
A. Ulys
A. Matulevicius
F. Jankevicius
S. Jarmalaite
Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis
European Urology Open Science
title Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis
title_full Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis
title_fullStr Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis
title_full_unstemmed Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis
title_short Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis
title_sort sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups lithuanian national cancer institute retrospective analysis
url http://www.sciencedirect.com/science/article/pii/S2666168320362339
work_keys_str_mv AT vurbonas sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis
AT azalimas sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis
AT ddabkeviciene sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis
AT aulys sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis
AT amatulevicius sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis
AT fjankevicius sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis
AT sjarmalaite sunitinibinpatientswithmetastaticrenalcellcarcinomaofintermediateandhighriskgroupslithuaniannationalcancerinstituteretrospectiveanalysis